Neuraxis, Inc NRXS Stock Forecast
AI-powered price prediction and analysis for Neuraxis, Inc · Alpha · vs marketSwitch to Total
Share
See NRXS's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.
Price Chart
Key Statistics
About Neuraxis, Inc
Neuraxis, Inc (NRXS) operates within the Industrial Applications and Services sector, specifically in the Electromedical & Electrotherapeutic Apparatus industry.
Latest News
Where NRXS sits on the market map
Electromedical & Electrotherapeutic Apparatus Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | AI Signal | Market Cap | P/E |
|---|---|---|---|
| NRXS Neuraxis, Inc | $77M | – | |
| MDT Medtronic Plc | $134.10B | 25.8x | |
| LIVN Livanova Plc | $5.02B | 34.9x | |
| ITGR Integer Holdings Corp | $4.31B | 43.7x | |
| AXGN Axogen, Inc. | $2.91B | – | |
| TMDX Transmedics Group, Inc. | $2.39B | 18.4x | |
| CNMD Conmed Corp | $1.57B | 19.6x | |
| CBLL Ceribell, Inc. | $998M | – | |
| INMD Inmode Ltd. | $770M | 6.8x | |
| CV Capsovision, Inc | $310M | 7.4x | |
| ELMD Electromed, Inc. | $224M | 20.6x | |
| FOCL Edap Tms Sa | $159M | – | |
| STXS Stereotaxis, Inc. | $105M | – | |
| VANI Vivani Medical, Inc. | $94M | – | |
| ECOR Electrocore, Inc. | $79M | – | |
| OM Outset Medical, Inc. | $77M | – | |
| HYPR Hyperfine, Inc. | $73M | – | |
| POCI Precision Optics Corporation, Inc. | $54M | – | |
| POSC Positron Corp | $54M | – | |
| QTI Qt Imaging Holdings, Inc. | $30M | – | |
| ITOC Itonic Holdings Ltd | $12M | – | |
| IRIX Iridex Corp | $12M | – | |
| GTHP Guided Therapeutics Inc | $10M | – | |
| NDRA Endra Life Sciences Inc. | $8M | – | |
| ADMT Adm Tronics Unlimited, Inc. | $6M | – | |
| NUWE Nuwellis, Inc. | $2M | – | |
| ESMC Escalon Medical Corp | $1M | 1.5x | |
| NXL Nexalin Technology, Inc. | $1M | – | |
| YBGJ Yubo International Biotech Ltd | N/A | – |
FAQ
Is Neuraxis, Inc a good stock to buy?
Our AI analyzes Neuraxis, Inc daily. Check the signal above for the latest recommendation. Always do your own research before investing.
How accurate are Neuraxis, Inc predictions?
For NRXS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 21.0%, measured on 300 forecast dates between 2023-09-22 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 32.0%, measured on 343 forecast dates between 2023-09-22 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are forecasts updated?
Neuraxis, Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Neuraxis, Inc? View full institutional-grade analysis on Intratio →
AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.